<p>Characteristics of hypertensive patients at baseline (T0) and after 6-months antihypertensive therapy (T1).</p
<p>Baseline characteristics of patients who were treated with statin and those who were not.</p
<p><sup>*</sup>waist-hip-ratio</p><p><sup>#</sup>systolic blood pressure.</p><p>The characteristics ...
<p>Sociodemographic characteristics of hypertensive patients at JUSH hypertension clinic.</p
<p>Characteristics of hypertensive patients at baseline (T0) and control subjects.</p
<p>Characteristics of unmedicated and medicated hypertensive participants after propensity score mat...
<p>Values are means ±SD or percentage.</p><p>*P <0.05 and</p><p>**P <0.01 compared with controls.</p...
<p>Clinical-biochemical parameters and drug treatment of hypertensive patients at start (baseline) a...
Baseline clinical characteristics of patients who were followed up for 6 months.</p
Hypertension control at 3 months, stratified by baseline participant characteristics.</p
<p>Patient characteristics at start of therapy (baseline, BL) with n = 8 for ECP 80 mmHg and n = 7 f...
<p>Characteristics of the study subjects at baseline and at 21 months post-treatment.</p
<p>Baseline characteristics of all patients who started treatment with PegIFN/RBV.</p
<p>Hypertension was defined as a systolic blood pressure ≥140 or diastolic ≥90mm Hg or the current u...
<p>Baseline characteristics of patients at the time of initiation of Tuberculosis (TB) therapy (N = ...
<p>Clinical characteristics at baseline of pituitary patients treated for adrenal insufficiency (N =...
<p>Baseline characteristics of patients who were treated with statin and those who were not.</p
<p><sup>*</sup>waist-hip-ratio</p><p><sup>#</sup>systolic blood pressure.</p><p>The characteristics ...
<p>Sociodemographic characteristics of hypertensive patients at JUSH hypertension clinic.</p
<p>Characteristics of hypertensive patients at baseline (T0) and control subjects.</p
<p>Characteristics of unmedicated and medicated hypertensive participants after propensity score mat...
<p>Values are means ±SD or percentage.</p><p>*P <0.05 and</p><p>**P <0.01 compared with controls.</p...
<p>Clinical-biochemical parameters and drug treatment of hypertensive patients at start (baseline) a...
Baseline clinical characteristics of patients who were followed up for 6 months.</p
Hypertension control at 3 months, stratified by baseline participant characteristics.</p
<p>Patient characteristics at start of therapy (baseline, BL) with n = 8 for ECP 80 mmHg and n = 7 f...
<p>Characteristics of the study subjects at baseline and at 21 months post-treatment.</p
<p>Baseline characteristics of all patients who started treatment with PegIFN/RBV.</p
<p>Hypertension was defined as a systolic blood pressure ≥140 or diastolic ≥90mm Hg or the current u...
<p>Baseline characteristics of patients at the time of initiation of Tuberculosis (TB) therapy (N = ...
<p>Clinical characteristics at baseline of pituitary patients treated for adrenal insufficiency (N =...
<p>Baseline characteristics of patients who were treated with statin and those who were not.</p
<p><sup>*</sup>waist-hip-ratio</p><p><sup>#</sup>systolic blood pressure.</p><p>The characteristics ...
<p>Sociodemographic characteristics of hypertensive patients at JUSH hypertension clinic.</p